Example: Heart Attack

Clinical Trials on Mucormycosis

Total 15 results

NCT03387696

Unknown status

Mucormycosis in ICU

Conditions: Mucormycosis
NCT02845934

Completed

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis

Conditions: Mucormycosis
NCT02226705

Unknown status

Endoscopic Surgical Treatment of Rhino-Sinusal Mucormycosis

Conditions: Rhinocerebral Mucormycosis
NCT04502381

Recruiting

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis

Conditions: Pulmonary Mucormycosis
NCT00419770

Completed

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Conditions: Mucormycosis
NCT04550936

Not yet recruiting

Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis

Conditions: Invasive Aspergillosis; Mucormycosis
NCT03816176

Recruiting

A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

Conditions: Invasive Mucormycosis; Invasive Aspergillosis
NCT00467883

Completed

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment

Conditions: Zygomycosis
NCT04744454

Not yet recruiting

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

Conditions: Aspergillosis; Mucormycosis
NCT03429023

Completed

Descriptive Epidemiology on Management of Mucormycosis

Conditions: Mycoses
NCT00923832

Completed

Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

Conditions: Immunocompromised Host; Invasive Pulmonary Fungal Infection; Invasive Pulmonary Aspergillosis; Invasive Pulmonary Zygomycosis
NCT00034671

Completed

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

Conditions: Mycoses
NCT04647539

Completed

Emerging Invasive Fungal Infections in Critically Ill Patients

Conditions: Fungal Infection; ICU Acquired Weakness
NCT04368221

Completed

Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU

Conditions: Covid-19
NCT03471988

Active, not recruiting

Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

Conditions: Deep Mycosis